SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

TRACON Pharmaceuticals Q1 EPS $(0.780) Beats $(1.090) Estimate

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.780) per share which beat the analyst consensus estimate of $(1.090) by 28.44 percent. This is a 225 percent decrease over losses of $(0.240) per

Benzinga · 05/13/2020 20:04

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.780) per share which beat the analyst consensus estimate of $(1.090) by 28.44 percent. This is a 225 percent decrease over losses of $(0.240) per share from the same period last year.